The ROE as of November 2024 (TTM) for Cue Biopharma, Inc. (CUE) is -156.38%

According to Cue Biopharma, Inc.’s latest financial reports and current stock price. The company's current ROE is -156.38%. This represents a change of 294.63% compared to the average of -39.63% of the last 4 quarters.

Cue Biopharma, Inc. (CUE) Historical ROE (quarterly & annually)

How has CUE ROE performed in the past?

The mean historical ROE of Cue Biopharma, Inc. over the last ten years is -71.04%. The current -156.38% ROE has changed 120.14% with respect to the historical average. Over the past ten years (40 quarters), CUE's ROE was at its highest in in the June 2016 quarter at 0%. The ROE was at its lowest in in the September 2017 quarter at -114.87%.

Cue Biopharma, Inc. (CUE) ROE by Quarter and Year

Discovering the peaks and valleys of Cue Biopharma, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Cue Biopharma, Inc. (CUE) Average ROE

How has CUE ROE performed in the past?

The current ROE of Cue Biopharma, Inc. (CUE) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Cue Biopharma, Inc. (CUE) ROE vs. Peers

How is CUE’s ROE compared to its peers?

Cue Biopharma, Inc.’s ROE is greater than Coya Therapeutics, Inc. (-31.59%), greater than Lantern Pharma Inc. (-56.90%), less than Fennec Pharmaceuticals Inc. (31.99%), greater than Eliem Therapeutics, Inc. (-47.03%), greater than Anixa Biosciences, Inc. (-52.41%), greater than INmune Bio, Inc. (-115.51%), greater than IN8bio, Inc. (-197.15%), greater than PolyPid Ltd. (-1219.71%), greater than X4 Pharmaceuticals, Inc. (-32.51%), less than Galera Therapeutics, Inc. (21.95%), greater than Terns Pharmaceuticals, Inc. (-32.76%), greater than Day One Biopharmaceuticals, Inc. (-22.40%), greater than HOOKIPA Pharma Inc. (-49.25%), greater than Cognition Therapeutics, Inc. (-150.93%), greater than TFF Pharmaceuticals, Inc. (-310.17%), greater than TScan Therapeutics, Inc. (-58.72%), greater than Dermata Therapeutics, Inc. (-247.40%),

Build a custom stock screener for Cue Biopharma, Inc. (CUE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cue Biopharma, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Cue Biopharma, Inc. (CUE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Cue Biopharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.